shutterstock_1764329549_ben_photo

Ben Photo / Shutterstock.com

23 June 2021BiotechnologyThe C5 Group (American Conference Institute, The Canadian Institute, C5)

Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank

The C5 Group—which constitutes the ACI, The Canadian Institute and C5—invites WIPR readers to the conference on July 27-28, 2021, to find out exactly how these new developments will impact their practice and clients.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biosimilar boom could save billions, think tank claims

25 October 2017 Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.

‘Breaking’ patents would harm innovation: think tank

5 March 2019 The Information Technology and Innovation Foundation think tank has called on the US National Institutions of Health to maintain IP protection amid calls to “break” patents in order to lower drug prices.

More on this story

Biosimilar boom could save billions, think tank claims

25 October 2017 Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.

‘Breaking’ patents would harm innovation: think tank

5 March 2019 The Information Technology and Innovation Foundation think tank has called on the US National Institutions of Health to maintain IP protection amid calls to “break” patents in order to lower drug prices.

More on this story

Biosimilar boom could save billions, think tank claims

25 October 2017 Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.

‘Breaking’ patents would harm innovation: think tank

5 March 2019 The Information Technology and Innovation Foundation think tank has called on the US National Institutions of Health to maintain IP protection amid calls to “break” patents in order to lower drug prices.

More features

UPC bans Meril Life Sciences from selling infringing heart valve

‘We took Ravgen head-on’: How we won zero-damages and others didn't

White & Case hires experienced litigator from A&O Shearman

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sanofi subsidiary fends off $450m trade secrets case

Pfizer infringed haemophilia therapy patent, says court

Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar